Clopidogrel
What's New
Last Posted: Mar 25, 2021
- Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis.
Claassens Daniel M F et al. Circulation. Cardiovascular interventions 2021 CIRCINTERVENTIONS120009434 - Ischemic stroke and myocardial ischemia in clopidogrel users and the association with CYP2C19 loss-of-function homozygocity: a real-world study
N Gronich et al, The PGX journal, March 1, 2021 - Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy.
Westergaard Niels et al. Metabolites 2021 Feb 11(2) - Insight on the Genetics of Atrial Fibrillation in Puerto Rican Hispanics.
Gonzalez-Cordero Ariel F et al. Stroke research and treatment 2021 20218819896 - Implementation and management outcomes of pharmacogenetic CYP2C19 testing for clopidogrel therapy in clinical practice.
Russmann Stefan et al. European journal of clinical pharmacology 2020 Nov - Pharmacogenomics for Primary Care: An Overview.
Rollinson Victoria et al. Genes 2020 Nov 11(11) - Projected utility of pharmacogenomic testing among individuals hospitalized with COVID-19: A retrospective multicenter study in the United States.
Stevenson James M et al. Clinical and translational science 2020 Oct - A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?
Zhu Ye et al. Genetics in medicine : official journal of the American College of Medical Genetics 2020 Oct - Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic review and meta-analysis.
Biswas Mohitosh et al. Expert opinion on drug safety 2020 Oct - Patient insights on features of an effective pharmacogenomics patient portal.
Truong Tien M et al. Pharmacogenetics and genomics 2020 Dec 30(9) 191-200
More
About PGx PHGKB
PGx PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to medications....more
Content Summary
- NIH Information (1)
- COVID-19 (2)
- Human Genome Epidemiologic Studies (611)
- GWAS Studies (3)
- Human Genomics Translation/Implementation Studies (63)
- Genomic Tests Evidence Synthesis (23)
- Genomic Tests Guidelines (7)
- Tier-Classified Guidelines (2)
- Non-Genomics Precision Health (1)
- Reviews/Commentaries (31)
- Tools/Methods (2)
Common PGx Related Topics
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Oct 1, 2020
- Page last updated:Apr 26, 2021
- Content source: